BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,920,000 | -33.6% | 171,023 | -45.9% | 1.28% | -10.4% |
| Q1 2022 | $37,514,000 | +6.0% | 316,386 | +23.3% | 1.43% | +9.6% |
| Q4 2021 | $35,376,000 | +23.0% | 256,700 | +24.0% | 1.30% | +25.0% |
| Q3 2021 | $28,755,000 | +311.1% | 207,006 | +153.6% | 1.04% | +350.0% |
| Q4 2020 | $6,995,000 | -45.8% | 81,616 | -58.9% | 0.23% | -56.3% |
| Q3 2020 | $12,901,000 | -64.4% | 198,452 | -60.0% | 0.53% | -66.4% |
| Q2 2020 | $36,242,000 | +83.4% | 495,719 | -14.6% | 1.58% | +38.1% |
| Q1 2020 | $19,761,000 | -24.6% | 580,679 | +20.6% | 1.14% | +3.3% |
| Q4 2019 | $26,213,000 | +98.4% | 481,494 | +52.1% | 1.11% | +79.4% |
| Q3 2019 | $13,210,000 | -10.7% | 316,646 | -6.2% | 0.62% | +3.9% |
| Q2 2019 | $14,786,000 | -51.5% | 337,650 | -43.0% | 0.59% | -52.1% |
| Q1 2019 | $30,511,000 | +44.7% | 592,793 | +4.0% | 1.24% | +19.7% |
| Q4 2018 | $21,085,000 | -3.3% | 570,168 | -1.8% | 1.04% | +29.5% |
| Q3 2018 | $21,795,000 | +36.0% | 580,413 | +43.2% | 0.80% | +32.6% |
| Q2 2018 | $16,020,000 | +71.2% | 405,364 | +11.6% | 0.60% | +61.1% |
| Q1 2018 | $9,357,000 | -6.2% | 363,249 | -1.8% | 0.38% | -2.3% |
| Q4 2017 | $9,977,000 | +9.7% | 369,782 | +52.0% | 0.38% | +3.8% |
| Q3 2017 | $9,096,000 | -26.9% | 243,327 | -51.1% | 0.37% | -28.8% |
| Q2 2017 | $12,447,000 | – | 497,880 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |